Nipro Corporation Forms Consortium to Develop New Mpox Detection Kit
I'm PortAI, I can summarize articles.
Nipro Corporation has formed a consortium with the GHIT Fund, TBA Co. Ltd., JIHS, PATH, and INRB to develop a new Mpox detection kit. This collaboration aims to leverage Nipro's genetic testing and TBA's Iso-PAS technology, with prototype evaluations in the Democratic Republic of the Congo. The initiative seeks to enhance early treatment and prevent infection spread, particularly in regions with limited medical infrastructure.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments